Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654086-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 131.0;Alveolar cells type 2: 92.7;Ciliated cells: 103.1;Club cells: 111.5;granulocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 12.3;hTERT-RPE1: 3.7;RPTEC TERT1: 14.3;TIME: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 110000 Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.9 5.0 1.5 6.2 2.9 0.0 5.3 2.8 2.8 8.7 14.3 4.4 1.8 1.5 12.0 3.7 5.4 5.6 4.7 15.9 3.1 1.3 3.8 12.1 10.6 1.5 5.1 2.9 2.0 12.9 1.1 2.6 12.0 7.2 8.1 3.7 19.9 4.7 8.7 2.6 2.2 3.1 26.8 3.6 2.0 7.5 2.9 4.2 0.2 4.6 2.2 0.5 8.0 13.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.3 0.0 0.0 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.9 2.8 2.8 3.1 1.3 5.1 2.9 7.2 4.2 131.0 92.7 0.0 4.4 6.3 0.1 6.1 0.0 103.1 111.5 1.8 0.0 0.1 0.0 0.4 12.0 3.6 0.0 0.0 1.9 0.1 1.6 1.8 58.1 8.6 0.2 6.4 0.0 1.3 0.6 13.4 45.8 0.6 0.0 0.0 0.0 0.0 1.5 0.0 15.9 0.6 0.2 25.8 0.5 1.8 1.3 1.0 0.1 0.0 0.0 1.7 AMTN "RSTI689, UNQ689" ENSG00000187689 Amelotin Q6UX39 4 70518540-70532742 "Disease related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 1.1;Urothelial cells: 1.3" "Group enriched" "Detected in many" 11 "cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 14.9;hTERT-RPE1: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036136, HPA036137" Uncertain "Secreted in other tissues" NA NA "HPA036136: AB_2674963, HPA036137: AB_10673614" "unprognostic (1.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.86e-2)" "unprognostic (7.35e-2)" "unprognostic (2.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.8 12.9 0.0 0.0 0.5 0.0 0.0 0.6 0.0 6.7 0.2 0.0 0.0 0.9 0.9 24.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 21.2 0.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 ANOS1 "ADMLX, KAL, KAL1, KALIG-1, WFDC19" ENSG00000011201 "Anosmin 1" P23352 X 8528874-8732186 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;lung: 37.1;parathyroid gland: 27.7" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 1: 223.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3" "Secreted in brain" NA NA "unprognostic (2.93e-1)" "unprognostic (5.33e-2)" "unprognostic (9.54e-2)" "unprognostic (4.16e-3)" "unprognostic (7.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-2)" "unprognostic (6.43e-2)" "unprognostic (2.09e-2)" "unprognostic (6.24e-2)" "unprognostic (1.71e-2)" "unprognostic (9.38e-3)" "unprognostic (6.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.56e-2)" 5.4 4.0 13.8 1.3 14.0 0.6 3.6 1.3 18.0 4.5 1.0 7.3 1.3 0.7 0.9 3.2 1.6 1.4 1.9 4.6 11.1 7.9 1.1 1.1 37.1 1.8 5.7 6.0 0.9 0.8 27.7 1.0 1.4 19.3 4.1 1.3 6.0 2.8 4.5 10.9 3.0 0.9 1.1 25.5 1.1 1.1 5.0 8.5 1.3 8.5 1.0 1.2 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.4 2.6 0.1 3.5 0.3 3.8 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.1 25.9 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 1.1 0.3 0.0 3.2 0.0 0.6 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.0 1.3 7.6 11.1 7.9 5.7 6.0 19.3 8.5 223.4 9.3 0.0 4.2 0.0 6.4 6.2 0.0 6.7 36.4 0.0 3.9 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 1.5 2.9 1.1 0.0 5.2 0.0 0.0 2.5 2.2 0.0 0.6 1.4 0.0 0.0 0.0 21.4 0.8 0.0 1.1 0.0 1.5 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.1 0.8 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 47.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced NA NA "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.9 2.4 0.5 0.0 1.0 0.0 21.3 0.3 0.0 0.0 0.2 7.6 2.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 0.0 13.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.8 0.0 4.0 1.2 1.8 0.0 0.0 0.0 1.4 0.4 1.9 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 47.7 0.0 3.1 1.5 1.1 0.0 0.0 0.0 0.0 0.4 1.0 0.1 0.0 0.4 0.0 1.5 0.0 0.8 5.0 6.4 1.0 0.1 0.0 0.5 1.0 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell type enhanced" "Detected in single" 14 "Bipolar cells: 1.1" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.8;HAP1: 5.6;hTERT-RPE1: 5.2;SuSa: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved NA NA "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 1.9 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 0.0 0.0 0.0 0.0 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CHRDL1 "CHL, MGC1, NRLN1" ENSG00000101938 "Chordin like 1" Q9BU40 X 110673856-110795819 "Disease related genes, Predicted secreted proteins" "Differentiation, Neurogenesis, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 21 "Leydig cells: 38.0;Muller glia cells: 79.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 24 "dendritic cells: 2.5" "Group enriched" "Detected in some" 9 "ASC diff: 93.3;ASC TERT1: 128.4;hTERT-RPE1: 58.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000226, HPA000250" Approved "Secreted in other tissues" NA NA 620000 "HPA000226: AB_1078522, HPA000250: AB_1078521" "unprognostic (5.13e-2)" "unprognostic (6.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.48e-3)" "unprognostic (1.99e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.42e-2)" "unprognostic (4.89e-2)" "unprognostic (5.54e-2)" "unprognostic (3.43e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (4.75e-3)" "unprognostic (7.91e-2)" "unprognostic (5.01e-2)" "prognostic unfavorable (2.23e-4)" 53.1 2.2 7.2 11.5 12.3 0.2 40.8 3.7 8.4 22.0 25.7 1.4 40.9 3.1 57.3 29.5 18.7 18.1 14.2 22.0 5.4 1.7 4.5 0.7 27.6 7.5 1.7 6.8 7.5 3.6 51.4 2.8 15.2 2.2 46.1 11.1 15.2 8.5 73.9 3.2 6.9 7.7 31.0 3.4 6.5 8.6 5.8 2.4 0.8 14.9 23.7 3.4 16.3 11.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 93.3 128.4 0.0 1.2 0.5 3.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.2 0.0 58.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.6 9.8 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 7.2 12.3 3.7 8.4 5.4 1.7 1.7 6.8 2.2 2.4 0.0 2.4 0.0 0.0 4.2 1.0 1.2 0.0 2.7 3.4 1.8 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.1 15.1 0.2 1.1 0.0 0.2 0.0 0.0 2.5 0.0 0.2 38.0 2.4 8.5 0.0 0.0 79.4 0.0 0.0 8.5 2.2 2.5 0.0 2.8 0.1 9.1 3.9 0.1 0.0 0.0 0.1 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714558 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 121.0;Intestinal endocrine cells: 27.5;Muller glia cells: 53.3;Rod photoreceptor cells: 35.9" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Group enriched" "Detected in some" 7 "GAMG: 71.3;hTERT-HME1: 29.1;hTERT-RPE1: 79.5;U-138 MG: 49.2;U-87 MG: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced NA NA 2700000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.7 45.6 25.4 2.2 26.8 1.3 3.1 19.5 85.2 2.2 2.3 38.4 0.0 1.6 2.1 5.7 1.5 4.1 1.5 6.8 23.9 36.8 9.7 1.3 2.0 1.5 39.8 15.2 1.6 1.9 1.7 9.6 1.5 30.0 2.8 2.2 2.5 46.1 1.6 1.3 2.5 1.9 2.2 26.4 1.3 8.3 2.0 30.4 0.0 1.4 0.0 2.1 1.4 0.2 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.1 0.0 0.0 0.2 1.6 0.5 0.0 0.2 0.0 0.0 0.0 71.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.5 1.7 1.2 29.1 79.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.3 0.0 2.8 0.0 5.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 49.2 0.0 1.6 7.3 0.0 0.0 0.0 29.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 25.4 26.8 19.5 26.6 23.9 36.8 39.8 15.2 30.0 30.4 0.0 0.0 0.0 5.8 0.3 121.0 10.3 0.0 14.7 0.0 3.5 13.7 0.0 1.7 0.2 6.8 0.0 0.0 0.0 1.2 0.1 0.8 3.8 0.0 0.0 0.1 11.1 27.5 0.0 0.0 1.3 5.5 1.0 18.6 0.0 0.0 53.3 0.5 0.0 5.6 0.8 35.9 0.0 0.5 0.7 1.1 0.0 0.1 0.0 0.0 0.4 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTERT-RPE1: 8.2;U-266/70: 2.0" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FPR3 "FMLPY, FPRH1, FPRL2, RMLP-R-I" ENSG00000187474 "Formyl peptide receptor 3" P25089 19 51795163-51826189 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.9" "Group enriched" "Detected in some" 10 "Hofbauer cells: 59.4;Kupffer cells: 71.5;Macrophages: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4" "Group enriched" "Detected in many" 43 "dendritic cells: 3.4;monocytes: 9.6" "Group enriched" "Detected in some" 4 "HEL: 14.7;hTERT-RPE1: 4.2" NA NA "unprognostic (3.77e-2)" "unprognostic (1.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-1)" "unprognostic (1.84e-1)" "unprognostic (8.41e-2)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (7.14e-2)" "unprognostic (3.17e-1)" "unprognostic (9.37e-2)" "unprognostic (1.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (1.96e-1)" "unprognostic (4.28e-2)" 35.9 10.0 1.5 12.9 2.1 0.0 6.2 0.6 1.8 3.2 6.6 1.8 0.5 5.9 3.1 7.0 3.4 3.0 10.7 6.3 1.7 1.2 6.8 13.0 25.9 15.1 2.8 0.9 5.4 3.2 0.7 2.2 5.2 2.4 5.0 10.3 4.9 5.1 1.3 4.6 2.3 10.9 4.6 5.2 10.8 3.4 3.3 1.1 8.0 2.7 6.4 10.1 9.3 2.6 0.0 3.4 0.1 9.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 9.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 1.5 2.1 0.6 1.8 1.7 1.2 2.8 0.9 2.4 1.1 0.0 1.7 2.4 0.0 4.9 0.0 0.3 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.2 0.0 0.5 59.4 0.0 0.0 1.8 71.5 0.0 0.3 66.8 6.8 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.7 0.0 0.0 0.0 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 IL33 "C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV" ENSG00000137033 "Interleukin 33" O95760 9 6215786-6257983 "Predicted intracellular proteins, Predicted secreted proteins" Transcription Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 19.9;U-2197: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007057, HPA022899, HPA024426" Supported Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA Nucleoplasm Vesicles "CAB007057: , HPA022899: , HPA024426: AB_1845820" "prognostic favorable (4.42e-4)" "unprognostic (8.36e-2)" "unprognostic (5.67e-3)" "unprognostic (7.67e-3)" "unprognostic (4.27e-1)" "unprognostic (1.63e-1)" "unprognostic (2.59e-3)" "unprognostic (2.66e-3)" "unprognostic (3.18e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (8.08e-2)" "unprognostic (1.58e-3)" "unprognostic (4.70e-3)" "unprognostic (4.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.85e-3)" 19.7 8.6 13.7 17.7 13.2 0.0 14.8 7.4 6.7 33.0 16.7 4.6 9.1 3.4 29.2 14.8 32.3 13.5 13.8 29.6 12.7 5.6 3.9 22.3 22.0 57.7 5.8 7.9 18.6 2.5 1.9 6.0 25.2 5.9 39.8 8.3 16.6 9.5 13.9 6.6 18.1 9.6 42.0 6.3 7.9 21.6 9.2 6.0 1.3 13.9 11.6 17.4 53.2 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.1 0.1 19.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 13.2 7.4 6.7 12.7 5.6 5.8 7.9 5.9 6.0 6.0 11.1 0.0 10.2 21.5 0.0 5.6 7.6 112.4 135.4 0.0 0.0 0.0 0.0 2.2 0.6 153.6 0.0 23.3 6.7 0.0 9.7 1.7 1.1 2.6 0.1 0.0 10.3 400.8 26.5 0.7 19.0 1.5 1.7 0.0 0.0 9.6 7.1 0.0 11.7 0.0 0.0 0.0 12.4 0.0 0.4 42.3 0.1 1.5 0.1 1.7 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296533-68432162 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.3;Fibroblasts: 8.2;Leydig cells: 6.4;Peritubular cells: 12.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 55.3;hTERT-RPE1: 83.9;U-138 MG: 38.5;WM-115: 21.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 4 "basal ganglia: 6.1" HPA051813 Uncertain NA NA 42000 "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 4.5 2.9 0.4 3.5 0.9 0.0 2.9 0.5 3.6 41.9 1.5 0.9 3.5 0.6 59.6 11.4 2.6 8.0 3.4 9.0 0.5 0.5 4.9 0.7 1.3 0.5 0.8 0.5 15.7 0.8 0.2 1.5 2.2 1.3 4.5 1.4 1.5 0.9 8.9 1.9 2.1 1.6 30.2 0.9 4.0 1.3 3.4 0.7 0.2 1.8 5.8 0.7 5.6 7.4 1.7 1.3 1.8 1.0 0.8 1.5 0.1 0.0 0.0 0.1 0.2 1.8 0.0 0.0 3.7 7.1 0.8 0.2 0.0 0.0 0.0 0.2 55.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.0 0.0 4.8 0.0 3.1 0.6 0.0 1.5 0.1 83.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 8.7 0.0 0.1 2.3 38.5 0.2 0.8 0.0 0.0 0.0 0.0 5.7 0.0 21.3 1.6 1.0 0.9 1.2 0.9 1.5 0.8 1.1 1.0 0.7 1.7 1.3 1.2 1.8 0.8 0.8 1.3 1.0 0.1 0.4 0.9 0.5 3.6 0.5 0.5 0.8 0.5 1.3 0.7 0.0 0.0 0.0 0.6 0.7 1.3 10.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.3 1.0 0.0 0.0 0.0 0.1 8.2 0.4 0.0 0.8 0.3 0.0 0.0 2.5 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 12.7 0.0 1.9 19.4 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 PCDHGB7 "ME6, PCDH-GAMMA-B7" ENSG00000254122 "Protocadherin gamma subfamily B, 7" Q9Y5F8 5 141417645-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Bipolar cells: 7.4;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 38.8;HSkMC: 12.3;hTERT-RPE1: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.22e-2)" "unprognostic (2.55e-2)" "unprognostic (7.39e-3)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (8.40e-2)" "unprognostic (4.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.88e-2)" "unprognostic (3.05e-1)" "unprognostic (2.22e-2)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (5.68e-2)" 10.1 9.8 12.6 3.8 13.5 0.8 8.0 19.1 12.9 10.2 7.0 16.1 1.2 2.3 11.6 5.0 6.8 7.8 9.2 8.5 14.5 7.9 5.4 3.5 11.6 2.6 10.4 7.3 17.3 5.5 9.5 5.3 11.0 9.4 8.3 3.8 15.5 7.1 12.0 5.6 6.8 3.2 10.5 20.1 5.3 4.5 4.2 14.3 0.6 8.4 3.0 2.3 4.6 6.9 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 38.8 0.9 0.1 0.4 2.5 0.3 0.9 1.9 0.0 2.3 0.3 2.1 5.1 0.3 0.6 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 2.9 0.2 0.0 12.3 0.3 0.7 0.4 32.9 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 4.3 0.8 0.0 0.1 0.0 4.2 5.8 0.1 0.0 0.0 0.5 0.4 0.4 5.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.6 13.5 19.1 12.9 14.5 7.9 10.4 7.3 9.4 14.3 3.0 2.2 0.0 0.5 0.3 7.4 1.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.1 0.8 0.3 1.1 0.0 0.1 3.2 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.7 0.0 1.8 0.2 0.4 0.0 1.4 0.0 0.1 0.4 0.0 0.0 0.0 0.1 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 123.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 380000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 5.9 13.6 0.8 7.5 1.3 0.0 4.1 2.1 1.5 25.9 52.2 1.8 26.1 2.9 36.9 10.3 22.6 20.9 11.1 31.6 1.0 0.4 2.0 1.5 2.7 5.9 0.9 1.3 9.3 1.9 0.5 1.2 1.7 1.3 37.1 7.6 4.3 2.9 51.1 8.5 2.2 15.4 123.0 1.5 1.7 16.6 4.3 0.9 0.9 2.8 4.5 1.5 57.4 24.5 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 4.2 3.4 2.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 29.8 0.0 20.7 0.9 0.9 0.0 0.0 0.1 0.0 25.9 1.4 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.8 1.3 2.1 1.5 1.0 0.4 0.9 1.3 1.3 0.9 0.0 1.7 0.0 5.1 2.1 22.3 88.7 0.0 1.4 3.4 12.2 3.9 0.0 1.7 0.1 1.2 35.0 0.0 0.0 0.0 0.1 3.3 2.7 0.0 0.0 0.1 0.0 0.0 31.9 3.2 0.0 7.5 1.9 3.3 1.8 0.0 8.4 0.1 0.0 4.6 0.6 1.1 51.8 36.4 0.1 0.2 2.0 0.0 0.0 0.0 1.3 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 146 "placenta: 495.8" "Cell type enriched" "Detected in some" 171 "Syncytiotrophoblasts: 1321.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 495.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.7 0.4 0.1 0.0 0.0 0.0 0.5 0.6 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.5 6.3 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1321.0 0.0 0.0 0.0 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Group enriched" "Detected in some" 18 "Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm NA NA Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.3 0.0 5.9 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 31.9 12.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 0.0 0.0 0.0 0.0 0.0 197.9 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 174.8 1.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 357.8 0.0 0.0 0.0 0.6 13.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3